Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (661-670 of 3,665) with videos related to

Pageof 367
Sort By:
Clinical Therapeutics|January 15, 2021
Targeting the Dysfunctional Placenta to Improve Pregnancy Outcomes Based on Lessons Learned in CancerRebecca L Wilson, Helen N Jones
Journal of Clinical Microbiology|October 1, 1987
Reliability of high-content disks and modified broth dilution tests for detecting staphylococcal resistance to the penicillinase-resistant penicillinsA L Barry, R N Jones
European Journal of Clinical Microbiology|April 1, 1987
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility testA L Barry, R N Jones
Journal of Clinical Microbiology|November 1, 1987
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporinR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)R N Jones, A L Barry
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
Ceftaroline applications for therapy in the United StatesG Ralph Corey, Ronald N Jones
Annals of Surgery|December 1, 1972
Pathophysiology and management of hypotension following declamping of abdominal aortaP Spyrou, N Jones, T Matsumoto
Diagnostic Microbiology and Infectious Disease|January 1, 1988
BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolatesR N Jones, A L Barry
Biometrics|June 1, 1988
Fitting mixture models to grouped and truncated data via the EM algorithmG J McLachlan, P N Jones
Diagnostic Microbiology and Infectious Disease|May 1, 1987
Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disksR N Jones, A L Barry
Pageof 367

Showing results (661-670 of 3,665) with videos related to

Sort By:
Pageof 367
Clinical Therapeutics|January 15, 2021
Targeting the Dysfunctional Placenta to Improve Pregnancy Outcomes Based on Lessons Learned in CancerRebecca L Wilson, Helen N Jones
Journal of Clinical Microbiology|October 1, 1987
Reliability of high-content disks and modified broth dilution tests for detecting staphylococcal resistance to the penicillinase-resistant penicillinsA L Barry, R N Jones
European Journal of Clinical Microbiology|April 1, 1987
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility testA L Barry, R N Jones
Journal of Clinical Microbiology|November 1, 1987
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporinR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)R N Jones, A L Barry
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
Ceftaroline applications for therapy in the United StatesG Ralph Corey, Ronald N Jones
Annals of Surgery|December 1, 1972
Pathophysiology and management of hypotension following declamping of abdominal aortaP Spyrou, N Jones, T Matsumoto
Diagnostic Microbiology and Infectious Disease|January 1, 1988
BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolatesR N Jones, A L Barry
Biometrics|June 1, 1988
Fitting mixture models to grouped and truncated data via the EM algorithmG J McLachlan, P N Jones
Diagnostic Microbiology and Infectious Disease|May 1, 1987
Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disksR N Jones, A L Barry
Pageof 367